Loading…

Clinical and pathological characteristics of peripheral T‐cell lymphomas in a Spanish population: a retrospective study

We investigated the clinicopathological features and prognostic factors of patients with peripheral T‐cell lymphoma (PTCL) in 13 sites across Spain. Relevant clinical antecedents, CD30 expression and staining pattern, prognostic indices using the International Prognostic Index and the Intergruppo It...

Full description

Saved in:
Bibliographic Details
Published in:British journal of haematology 2021-01, Vol.192 (1), p.82-99
Main Authors: Rodriguez‐Pinilla, Socorro Maria, Domingo‐Domenech, Eva, Climent, Fina, Sanchez, Joaquin, Perez Seoane, Carlos, Lopez Jimenez, Javier, Garcia‐Cosio, Monica, Caballero, Dolores, Blanco Muñez, Oscar Javier, Carpio, Cecilia, Castellvi, Josep, Martinez Pozo, Antonio, Gonzalez Farre, Blanca, Bendaña, Angeles, Aliste, Carlos, Gonzalez, Ana Julia, Gonzalez de Villambrosia, Sonia, Piris, Miguel A., Gomez Codina, Jose, Mayordomo‐Aranda, Empar, Navarro, Belen, Bellas, Carmen, Rodriguez, Guillermo, Borrero, Juan Jose, Ruiz‐Zorrilla, Ana, Grande, Marta, Montoto, Carmen, Cordoba, Raul
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We investigated the clinicopathological features and prognostic factors of patients with peripheral T‐cell lymphoma (PTCL) in 13 sites across Spain. Relevant clinical antecedents, CD30 expression and staining pattern, prognostic indices using the International Prognostic Index and the Intergruppo Italiano Linfomi system, treatments, and clinical outcomes were examined. A sizeable proportion of 175 patients had a history of immune‐related disorders (autoimmune 16%, viral infections 17%, chemo/radiotherapy‐treated carcinomas 19%). The median progression‐free survival (PFS) and overall survival (OS) were 7·9 and 15·8 months, respectively. Prognostic indices influenced PFS and OS, with a higher number of adverse factors resulting in shorter survival (P 
ISSN:0007-1048
1365-2141
DOI:10.1111/bjh.16741